Emcure Pharmaceuticals Ltd.
EMCURE
Kedudukan dalam Saham
#4336
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Harga Saham
$18.87
Modal Pasaran
$3.58B
Perubahan (1 hari)
-2.83%
Perubahan (1 tahun)
19.28%
Negara
IN
Perdagangan Emcure Pharmaceuticals Ltd. (EMCURE)
Kategori
Healthcare
Sejarah pecahan saham untuk Emcure Pharmaceuticals Ltd. (EMCURE)
Saham Emcure Pharmaceuticals Ltd. (simbol: EMCURE) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 22, 2026.
Satu saham EMCURE yang dibeli sebelum Oct 22, 2026 kini bersamaan dengan 0 saham EMCURE.
Pecahan saham terkini berlaku pada Oct 22, 2026.
Satu saham EMCURE yang dibeli sebelum Oct 22, 2026 kini bersamaan dengan 0 saham EMCURE.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
